Endothelium-derived Relaxing Factor Produced and Released from Artery and Vein is Nitric Oxide

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1987 Dec 1

PMID 2827174

Citations 991

Authors

L J Ignarro

G M Buga

K S Wood

R E Byrns

G Chaudhuri

Affiliations

Soon will be listed here.

Abstract

The objective of this study was to determine whether nitric oxide (NO) is responsible for the vascular smooth muscle relaxation elicited by endothelium-derived relaxing factor (EDRF). EDRF is an unstable humoral substance released from artery and vein that mediates the action of endothelium-dependent vasodilators. NO is an unstable endothelium-independent vasodilator that is released from vasodilator drugs such as nitroprusside and glyceryl trinitrate. We have repeatedly observed that the actions of NO on vascular smooth muscle closely resemble those of EDRF. In the present study the vascular effects of EDRF released from perfused bovine intrapulmonary artery and vein were compared with the effects of NO delivered by superfusion over endothelium-denuded arterial and venous strips arranged in a cascade. EDRF was indistinguishable from NO in that both were labile (t1/2 = 3-5 sec), inactivated by pyrogallol or superoxide anion, stabilized by superoxide dismutase, and inhibited by oxyhemoglobin or potassium. Both EDRF and NO produced comparable increases in cyclic GMP accumulation in artery and vein, and this cyclic GMP accumulation was inhibited by pyrogallol, oxyhemoglobin, potassium, and methylene blue. EDRF was identified chemically as NO, or a labile nitroso species, by two procedures. First, like NO, EDRF released from freshly isolated aortic endothelial cells reacted with hemoglobin to yield nitrosylhemoglobin. Second, EDRF and NO each similarly promoted the diazotization of sulfanilic acid and yielded the same reaction product after coupling with N-(1-naphthyl)-ethylenediamine. Thus, EDRF released from artery and vein possesses identical biological and chemical properties as NO.

Citing Articles

Integrins in Cardiovascular Health and Disease: Molecular Mechanisms and Therapeutic Opportunities.

Lawkowska K, Bonowicz K, Jerka D, Bai Y, Gagat M Biomolecules. 2025; 15(2).

PMID: 40001536 PMC: 11853560. DOI: 10.3390/biom15020233.

Vericiguat prevents high glucose-mediated impaired vascular smooth muscle cGMP production and vasorelaxation.

Polhemus D, Almodiel D, Harb T, Ziogos E, Amat-Codina N, Ranek M Sci Rep. 2025; 15(1):4939.

PMID: 39929946 PMC: 11811225. DOI: 10.1038/s41598-025-88938-w.

Promotion of nitric oxide production: mechanisms, strategies, and possibilities.

Gonzalez M, Clayton S, Wauson E, Christian D, Tran Q Front Physiol. 2025; 16:1545044.

PMID: 39917079 PMC: 11799299. DOI: 10.3389/fphys.2025.1545044.

Characteristics of Plasmodium vivax apicomplexan amino acid transporter 8 (PvApiAT8) in the cationic amino acid transport.

Lee W, Mazigo E, Han J, Cha S Sci Rep. 2025; 15(1):4234.

PMID: 39905186 PMC: 11794574. DOI: 10.1038/s41598-025-88746-2.

Vascular Endothelium at the Molecular Level: From Fundamental Knowledge Toward Medical Implementation.

Shirinsky V Biomedicines. 2025; 13(1).

PMID: 39857586 PMC: 11762819. DOI: 10.3390/biomedicines13010002.

References

Ignarro L, Burke T, Wood K, Wolin M, Kadowitz P . Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J Pharmacol Exp Ther. 1984; 228(3):682-90. View

Edwards J, Ignarro L, HYMAN A, Kadowitz P . Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP. J Pharmacol Exp Ther. 1984; 228(1):33-42. View

Ignarro L, Wood K, Ballot B, Wolin M . Guanylate cyclase from bovine lung. Evidence that enzyme activation by phenylhydrazine is mediated by iron-phenyl hemoprotein complexes. J Biol Chem. 1984; 259(9):5923-31. View

Burton K, McCord J, Ghai G . Myocardial alterations due to free-radical generation. Am J Physiol. 1984; 246(6 Pt 2):H776-83. DOI: 10.1152/ajpheart.1984.246.6.H776. View

Martin W, Villani G, Jothianandan D, FURCHGOTT R . Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther. 1985; 232(3):708-16. View

Ignarro L, Harbison R, Wood K, Wolin M, McNamara D, HYMAN A . Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate. J Pharmacol Exp Ther. 1985; 233(3):560-9. View

Martin W, Villani G, Jothianandan D, FURCHGOTT R . Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous hemoproteins. J Pharmacol Exp Ther. 1985; 233(3):679-85. View

Ignarro L, Adams J, Horwitz P, Wood K . Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms. J Biol Chem. 1986; 261(11):4997-5002. View

Forstermann U, Mulsch A, Bohme E, Busse R . Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res. 1986; 58(4):531-8. DOI: 10.1161/01.res.58.4.531. View

10.

Gryglewski R, Moncada S, Palmer R . Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br J Pharmacol. 1986; 87(4):685-94. PMC: 1916807. DOI: 10.1111/j.1476-5381.1986.tb14586.x. View

11.

Ignarro L, Harbison R, Wood K, Kadowitz P . Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther. 1986; 237(3):893-900. View

12.

Gruetter C, Lemke S . Comparison of endothelium-dependent relaxation in bovine intrapulmonary artery and vein by acetylcholine and A23187. J Pharmacol Exp Ther. 1986; 238(3):1055-62. View

13.

Mulsch A, Bohme E, Busse R . Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor from cultured endothelial cells. Eur J Pharmacol. 1987; 135(2):247-50. DOI: 10.1016/0014-2999(87)90620-0. View

14.

Palmer R, Ferrige A, Moncada S . Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987; 327(6122):524-6. DOI: 10.1038/327524a0. View

15.

BELL F, ONeill J, BURGISON R . Determination of the oil/water distribution coefficients of glyceryl trinitrate and two similar nitrate esters. J Pharm Sci. 1963; 52:637-9. DOI: 10.1002/jps.2600520706. View

16.

Vane J . THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD. Br J Pharmacol Chemother. 1964; 23:360-73. PMC: 1704098. DOI: 10.1111/j.1476-5381.1964.tb01592.x. View

17.

Marklund S, Marklund G . Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974; 47(3):469-74. DOI: 10.1111/j.1432-1033.1974.tb03714.x. View

18.

Schwartz S . Selection and characterization of bovine aortic endothelial cells. In Vitro. 1978; 14(12):966-80. DOI: 10.1007/BF02616210. View

19.

Gruetter C, Barry B, McNamara D, Gruetter D, Kadowitz P, Ignarro L . Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res. 1979; 5(3):211-24. View

20.

Gruetter C, Barry B, McNamara D, Kadowitz P, Ignarro L . Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N'-nitrosonornicotine and nitric oxide. J Pharmacol Exp Ther. 1980; 214(1):9-15. View